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Introduction
The human genome encodes approximately 290 Krüppel-associated box (KRAB) zinc finger proteins, but little is known about the biological functions of these proteins. Proteins in this family are characterized by the presence of the KRAB domain near the amino termini and multiple zinc finger motifs (4 to 30) at their carboxy termini. The KRAB domain is a potent repressor domain that spans approximately 75 amino acids. Repression by KRAB domains is mediated by the binding of the transcriptional co-repressor, transcriptional intermediary factor 1β (TIF1β) which is also known as KRAB-associated protein (KAP-1) or KRAB-A interacting proteins 1 (KRIP-1) (Friedman et al., 1996; Kim et al., 1996; Moosmann et al., 1996) . As this co-repressor protein interacts with KRAB domains from multiple origins, it is regarded as the common co-repressor of the KRAB-zinc finger proteins. The KRAB-TIF1β complex recruits heterochromatin-associated proteins such as HP1 (Ryan et al., 1999) and SETDB1 (Schultz et al., 2002) , which methylates lysine residue (K9) on the tail of histone 3 (H3). TIF1β also interacts with histone deacetylase complexes-NcoR1 (Underhill et al., 2000) and NuRD (Schultz et al., 2001) . By associating with those proteins through the KRAB domain, KRAB zinc finger proteins are thought to exert transcriptional repressor activity on their targets, which are recognized by zinc finger motifs. Most zinc finger motifs are involved in DNA binding; however, some of the KRAB-zinc finger family proteins, including ZBRK1, have been shown to bind both DNA and protein via its zinc finger motifs (Zheng et al., 2000) .
Zinc finger protein 133 (ZNF133) was identified as one of the KRAB-zinc finger family proteins . Like most proteins of this family, the biological function, mechanism of regulation, and target sequence of this protein largely remain unknown. The KRAB domain of ZNF133 was reported to have transcriptional repression activity and to interact with TIF1β (Friedman et al., 1996) . In several microarray studies, the expressions of ZNF133 were reported to be elevated in chronic myeloid leukemia (Li et al., 2002) and neuroblastoma cells (Heiskanen et al., 2000) , as well as by INFγ stimulation (Andersen et al., 2003) ; these findings suggest its possible role in oncogenesis and/or immune response. In this study, we show that, in addition to the KRAB domain, the zinc finger motifs of ZNF133 also mediate transcriptional repression via interaction with protein inhibitor of activated STAT1 (PIAS1), and this effect requires histone deacetylase (HDAC) activity.
Materials and Methods

Plasmids
Full-length cDNAs encoding ZNF133, TIF1β, and PIAS1 were cloned from human thymus cDNA (Clontech) into pCMV6-HA, myc, and SRT (Lee et al., 2001) , respectively. cDNAs encoding partial fragments of ZNF133 (amino acids 1-213 and 214-654) were subcloned into pCMV6-HA, and the C-terminal region of PIAS1 (424-651) was subcloned into pCMV6-SRT. Mammalian expression plasmids for GAL4-DNA-binding (DB) domain fusions GAL4-ZNF133 (1-654), GAL4-ZNF133 (1-213), and GAL4-ZNF133 (214-654) were generated on a pSV2-GAL4 background (pGH250) . For luciferase assay, (GAL4)5/ TK-Luc reporter plasmid (Rountree et al., 2000) was used.
Yeast two-hybrid screening
The bait plasmid was generated by subcloning a cDNA fragment encoding the zinc finger motifs (214-654) into the pLexA vector (Clontech). The EGY48 yeast strain was transformed by the bait plasmid and two-hybrid cDNA library DNA derived from human fetal brain (Clontech). About 10 6 transformants were screened and positive clones were selected for growth on plates lacking tryptophan, histidine, uracil, and leucine, and were subsequently tested for β-galactosidase activity.
Cell culture
HEK293 and HeLa cells were grown in DMEM supplemented with 10% FBS. For immunoprecipitation, HEK293 cells were transfected with the expression plasmids by the calcium phosphate precipitation method. HEK293 and HeLa cells were used for the luciferase assay and indirect immnofluorescence assay (IFA), respectively, and were transfected with LipofectAMINE reagents (Invitrogen).
Immunoprecipitation and immunoblotting
HEK293 cells were cotransfected with the HAtagged plasmids encoding either full-length, 1-213, or 214-654 amino acids of ZNF133 and the SRT-tagged plasmids encoding full-length or 424-651 amino acids of PIAS1. Forty-eight hours after transfection, cells were lysed with a lysis buffer (50 mM Tris-HCl, pH 8.0, 0.1% Triton X-100, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM PMSF, 1 mM sodium orthovanadate, 2 mM leupeptin). After clearing by centrifugation, total cell lysates were incubated with anti-SRT antibody. After 1 h incubation at 4 o C, protein A-Sepharose beads were added and adsorbed for another hour. Immune complexes were pelleted, washed twice with lysis buffer, and then washed twice with lysis buffer containing 100 mM NaCl. Precipitated proteins were resolved by SDS-PAGE and probed with the appropriate antibodies.
Immnofluorescence assay (IFA)
HeLa cells were grown on microscope slide cover slips and transfected with plasmids encoding SRTtagged ZNF133 and HA-tagged PIAS1. Forty-eight hours after transfection, cells were fixed in PBS with 1% paraformaldehyde and permeabilized with 0.1% Triton X-100 in PBS. After three washes in PBS, cells were incubated with anti-SRT mouse monoclonal antibody and biotin-conjugated anti-HA rat monoclonal antibody, followed by incubation with rhodamine-conjugated goat anti-mouse IgG and FITC-conjugated streptavidin.
Results
Transcriptional repressor activity by the zinc finger motifs of ZNF133
To assess whether the zinc finger motifs of ZNF133 contribute to transcriptional repressor activity, we performed the GAL4 DNA-tethering assays (Oh et al., 2005; Kim et al., 2006) . For this experiment, GAL4 DNA-binding domain fusion constructs containing zinc finger motifs (214-654), the N-terminal region (1-213), and full-length ZNF133 were generated ( Figure 1A ). Immunoblot analysis with cell extracts prepared from transfected HEK293 cells confirmed that the fusion proteins were expressed at similar levels ( Figure  1B ). Next, HEK293 cells were cotransfected with a luciferase reporter gene containing the GAL4 binding sites and the GAL4-ZNF133 fusions, and the luciferase assays were subsequently per- At 24 h after transfection, total cell extracts were prepared and assayed for luciferase activity. pCMV-β-gal plasmid was used as an internal transfection control. Transfection efficiency was normalized by β-galactosidase activity. The results, expressed as luciferase activities ± standard errors, are representative of at least three experiments.
formed. The results showed that GAL4-ZNF133 (1-213), GAL4-ZNF133 (214-654), and GAL4-ZNF133 (1-654) each efficiently repressed transcription of the reporter gene in dose-dependent manners. These data demonstrate that, like the KRAB domain, the zinc finger motifs also have the potential to repress transcription and may contribute to the overall transcriptional repressor activity of ZNF133.
PIAS1 interacts with the zinc finger motifs of ZNF133
In an attempt to investigate the mechanism of ZNF133 zinc finger motif-mediated transcriptional repression, a yeast two-hybrid cDNA library derived from human fetal brain was screened with the zinc finger motifs of ZNF133 as bait. Sequence analysis revealed that one of the positive clones contained the C-terminal region (424-651) of PIAS1 ( Figure 2A) . We further investigated the interaction of ZNF133 with PIAS1 in mammalian cells using coimmunoprecipitation assays. First, ZNF133 was coexpressed with either full-length PIAS1 or the C-terminal region (424-651) of PIAS1 in HEK293 cells. Immunoprecipitation of full-length PIAS1 or PIAS1 (424-651) resulted in coprecipitation of ZNF133, demonstrating that ZNF133 binds to the C-terminal region of PIAS1 ( Figure  2B ). A reciprocal experiment was also conducted by using expression plasmids for the KRAB domain or the zinc finger motifs of ZNF133, in combination with PIAS1 (424-651). The results showed that immunoprecipitation of PIAS1 (424-651) resulted in coprecipitation of the zinc finger motifs (214-654) of ZNF133, but not the KRAB domain (1-213) of ZNF133 ( Figure 2C ). Consistent with the finding from the yeast two-hybrid interaction assays, these results demonstrate that the zinc finger motifs of ZNF133 specifically bind to the C-terminal region of PIAS1. Intracellular localizations of these two proteins were also tested by IFA. SRT-ZNF133 and HA-PIAS1 were coexpressed in HeLa cells, and double-label IFA was performed with antibodies for SRT and HA tags. The results showed that both proteins were completely colocalized as nuclear speckles ( Figure 2D ), which supports our finding that PIAS1 interacts with ZNF133 in the nucleus.
PIAS1 enhances transcriptional repression by the zinc finger motifs of ZNF133
To determine the functional role of PIAS1 in transcriptional regulation by ZNF133, we investigated the effect of PIAS1 on ZNF133-mediated transcriptional repression. For this, we performed GAL4 DNA-tethering assays similar to those described in Figure 1C . We found that expression of PIAS1 augmented GAL4-ZNF133-mediated transcriptional repression in a dose-dependent manner, whereas it had little effect on the activity of GAL4 alone ( Figure 3A) . Similar effects of PIAS1 were observed for GAL4-ZNF133 (214-654)-mediated transcriptional repression ( Figure 3B ). Expression of TIF1β, which targets the KRAB domain and acts as a co-repressor, had no effect on the ZNF133 (214-654)-mediated transcriptional repression (Figure 3B). These results demonstrate that PIAS1 potentiates ZNF133-induced transcriptional repres- Figure 1C . Mean values and standard errors of luciferase activity from at least three independent experiments are shown. (B) Increasing amounts of plasmid encoding PIAS1 (10 to 160 ng) or TIF1β (10 to 160 ng) together with GAL4-ZNF133 (214-654) were transfected into HEK293 cells. After 24 h, luciferase activity was measured as described in A. sion by binding to the zinc finger motifs.
PIAS1-mediated augmentation of transcriptional repression by ZNF133 requires histone deacetylase activity
PIAS1 has been shown to interact with various transcription factors and regulate their transcriptional activities through several mechanisms, including recruitment of other transcriptional coregulators . To investigate whether histone deacetylase, which interacts with PIAS proteins (Tussie-Luna et al., 2002; Long et al., 2003; Gross et al., 2004) , mediates the regulatory activity of PIAS1 on ZNF133, we investigated the effect of the HDAC inhibitor, trichostatin A (TSA), on this process. The results of GAL4 DNA tethering assays showed that TSA treatment completely reversed the repression activities of both full-length ZNF133 and ZNF133 (214-654) (Figure 4) . Furthermore, TSA treatment also completely inhibited the augmentation effect of PIAS1 in ZNF133 (214-654)-mediated transcriptional repression ( Figure 4B ). These data suggest that recruitment of HDACs via PIAS1 may play a role in transcriptional repression by the zinc finger motifs of ZNF133.
Discussion
The KRAB zinc finger proteins make up one of the largest families of transcription factors. KRAB domains of this family of proteins have potent transcriptional repressor activity . Because TIF1β interacts with many KRAB domains of this family, TIF1β is proposed to act as the common co-repressor of KRAB zinc finger proteins (Friedman et al., 1996; Kim et al., 1996; Moosmann et al., 1996) .
Even though the role of the KRAB domain in transcriptional regulation has been characterized in depth, the role of zinc fingers has not yet been extensively studied. In general, this motif is required for DNA binding. However, in some proteins, this motif is also involved in binding with other proteins (Zheng et al., 2000) . In this study, using the GAL4-fusion proteins and a reporter gene containing GAL4 binding sites upstream of the minimal TK promoter, we found that, in addition to the well-known KRAB domain, the zinc finger motifs of ZNF133 also have transcriptional repressor activity. Furthermore, using a two-hybrid screening assay with the zinc finger motifs as bait, we also found that a transcriptional regulator, PIAS1, interacts with the zinc finger motifs of ZNF133.
PIAS1 was originally identified as an inhibitor of STAT1 (Liu et al., 1998) . A recent study showed that PIAS-deficient mice increase the expression of a subset of interferon-induced genes and increase the antiviral activity of interferon (Liu et al., 2004) , thus supporting the physiological role of PIAS1 as a STAT1 regulator in the innate immune response. However, PIAS1 has also been reported to bind and, therefore, regulate numerous transcription factors, including NF-κB and p53 (Kahyo et al., 2001; Megidish et al., 2002; Schmidt and Muller, 2002) , through several mechanisms. DNA binding of STAT1 and NF-κB is inhibited by PIAS1. PIASy, a member of the PIAS family, represses the transcriptional activity of STAT1 by recruiting histone deacetylases (Liu et al., 2001) .
Our data show that PIAS1 specifically binds to the zinc finger motifs of ZNF133, and this interaction augments ZNF133-mediated transcriptional repression. Furthermore, when we investigated whether HDAC inhibition could restore the PIAS1-induced repression, as seen with androgen receptor (Tan et al., 2000; Nishida and Yasuda, 2002) , it was found that TSA treatment efficiently inhibited the PIAS1-mediated repressor activities of the zinc finger motifs in a dose-dependent manner. Our data suggest that PIAS1 binds the zinc finger motifs and represses the transcription from the unidentified target sequence(s) by recruiting HDACs (Figure 5) .
Although the biological functions of ZNF133 and most of the KRAB zinc finger proteins remain elusive, it should also be noted that the expression of ZNF133 was reportedly increased by INFγ (Andersen et al., 2003) . Considering that PIAS1 regulates expression by interferons, it is tempting to speculate that PIAS1 recognizes its targets through transcription factors including ZNF133. Microarray studies have shown that expression of ZNF133 was elevated in chronic myeloid leukemia (Li et al., 2002) and neuroblastoma cells (Heiskanen et al., 2000) . With the knowledge that PIAS1 regulates the transcriptional activity of p53 (Kahyo et al., 2001; Megidish et al., 2002; Schmidt and Muller, 2002) , it is believed that ZNF133 could have roles in oncogenesis. Further studies are required to clarify those possibilities; in particular, identification of the target sequence would provide insight into the functional role of this protein.
